Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
IMbrella B: Atezolizumab Extension Study
NCT03768063Phase 3Active, not recruiting
- Sponsor
- Roche
- Start
- Feb 2019
- Primary completion
- Jul 2028
- Modality
- Monoclonal Antibodies
- Countries
- 24
01
Overview
A Phase 3 trial of atezolizumab in cancer, sponsored by Roche. Started Feb 2019; status: active, not recruiting.
02
Drugs
atezolizumab
03
Conditions
cancer
Beyond the preview
Go deeper on NCT03768063.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT03768063.